A survey among dermatological practitioners: How familiar are they with placebo and nocebo effects and is that knowledge applied in the clinical practice?

A survey among dermatological practitioners: How familiar are they with placebo and nocebo effects and is that knowledge applied in the clinical practice? - REQUEST

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00026094

Enrollment

362

Registered

2021-09-21

Start date

2021-09-22

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Not restricted to one specific disease, but concerned with the dermatological practice in general L00-L99

Interventions

Group 1: Dermatologists are asked about their knowledge of placebo and nocebo effects as well as about the influence that knowledge has on their clinical practice at one instance using a questionnaire

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Doctors employed in dermatological clinics and offices

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Descriptive analysis of doctors' statements with regard to knowledge about placebo and nocebo effects as well as their effect on the clinical practice	—

Secondary

Measure	Time frame
Analysis of the associations of replies to the above-mentioned questions and doctors' field of work, age, etc.	—

Countries

Germany

Contacts

Public ContactWiebke Sondermann

Universitätsklinikum Essen (AöR), Klinik für Dermatologie, Venerologie und Allergologie

wiebke.sondermann@uk-essen.de0201 723 3647

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026